A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog® in Type 1 Diabetes Mellitus Patients
Location: PAMF (Peninsula and South Bay)
Please contact Elizabeth Jameiro Jameire@sutterhealth.org about study Mylan’s Insulin AspartView study details on ClinicalTrials.gov
June 04, 2019
Investigator: Alice R. Pressman, Ph.D., M.S.